Table 4.

Sleep actigraphy data

	PEA			Placebo
	Baseline	Week 4	Week 8	Baseline	Week 4	Week 8
Total Sleep time (hrs)	7.49 ± 1.1	7.66 ± 1.2	7.58 ± 1.1	7.52 ± 1.2	7.54 ± 1.2	7.48 ± 1.1
Sleep Time (hrs)	7.00 ± 1.0	7.10 ± 1.0	7.03 ± 1.1	6.98 ± 1.2	7.02 ± 1.2	6.97 ± 1.1
Interruptions (min)	34.3 ± 14.1	32.3 ± 11.6	32.2 ± 11.2	32.1 ± 12.2	31.3 ± 12.4	30.9 ± 11.8
Sleep quality (1–5)	2.7 ± 0.6	3.1 ± 0.7	3.1 ± 0.7	2.5 ± 0.7	3.0 ± 0.7	2.9 ± 0.9
Sleep Continuity (1–5)	3.2 ± 0.9	3.2 ± 0.9	3.2 ± 0.9	3.2 ± 0.9	3.4 ± 1.0	3.3 ± 0.9
Sleep Percentage (%)	92.4 ± 3.9	92.9 ± 3.0	92.8 ± 2.4	92.8 ± 3.0	91.1 ± 7.5	93.0 ± 2.9

N.B. Data presented as mean ± standard deviation; total sleep time = sleep time + interruptions + sleep latency; PEA palmitoylethanolamide